NCT06596148
Improving Shingrix Vaccination Among US Veterans Receiving Immunosuppression
Enrolling by Invitation
NAAll AgesInterventionalPreventionUniversity of California, San FranciscoInvestigator-initiated
~130 participants
Updated 2025-04-06 on ClinicalTrials.gov
What's tested:Access to Shingrix dashboard
At a glance
Recruiting sites
0 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Percentage of patients with at least 1 Shingrix vaccine documented, by facility
Measured over From enrollment until end of follow up at 18 months.
Conditions
Where it's being run
1 sites across 1 statesCalifornia1
Study leadership
- Gabriela Schmajuk, MD MS · PRINCIPAL_INVESTIGATOR · San Francisco VA Medical Center
Who to contact
This trial hasn't published a contact. View it on ClinicalTrials.gov
Do you actually qualify for this trial?
Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.
Eligibility criteria
Inclusion
In order to be included in the study, clinicians need to work at a VHA facility and have access to the electronic health record.
Exclusion
None.
What this trial measures
- Percentage of patients with at least 1 Shingrix vaccine documented, by facilityFrom enrollment until end of follow up at 18 months.
Percentage of patients with at least 1 Shingrix vaccinations documented, by facility